Pricing

Pluri Inc (PLUR)

followers ·
Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
SERVICES-COMPUTER PROCESSING & DATA PREPARATION
CEO:
Yaky Yanay
Employees:
150
MATAM ADVANCED TECHNOLOGY PARK, BUILDING NO. 5, HAIFA, L3, 3508409
972-74-710-7171
Stock Split History
DateRatio
2007-11-26 1:2
2019-07-25 1:10
Pluristem Therapeutics Inc. focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available